Daniel N. Swisher, Jr

2020 - Jazz Pharmaceuticals

In 2020, Daniel N. Swisher, Jr earned a total compensation of $4.5M as President and COO at Jazz Pharmaceuticals, a 5% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$636,000
Option Awards$1,295,588
Salary$713,654
Stock Awards$1,809,598
Other$16,247
Total$4,471,087

Swisher received $1.8M in stock awards, accounting for 40% of the total pay in 2020.

Swisher also received $636K in non-equity incentive plan, $1.3M in option awards, $713.7K in salary and $16.2K in other compensation.

Rankings

In 2020, Daniel N. Swisher, Jr's compensation ranked 2,519th out of 13,090 executives tracked by ExecPay. In other words, Swisher earned more than 80.8% of executives.

ClassificationRankingPercentile
All
2,519
out of 13,090
81st
Division
Manufacturing
964
out of 5,618
83rd
Major group
Chemicals And Allied Products
347
out of 2,251
85th
Industry group
Drugs
298
out of 1,951
85th
Industry
Pharmaceutical Preparations
216
out of 1,456
85th

Pay ratio

Daniel N. Swisher, Jr's Pay$4,471,087
Median Employee's Pay$234,935
Pay Ratio

19

to 1

In 2020, the annual total compensation of Daniel N. Swisher, Jr was $4,471,087.

The annual total compensation of the median employee at Jazz Pharmaceuticals was $234,935.

The ratio of Daniel N. Swisher, Jr's pay to the pay of median employee was therefore 19 to one.

Source: SEC filing on June 11, 2021.

Swisher's colleagues

We found five more compensation records of executives who worked with Daniel N. Swisher, Jr at Jazz Pharmaceuticals in 2020.

2020

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2020

Kim Sablich

Jazz Pharmaceuticals

Executive Vice President and General Manager, North America

2020

Renée Gal

Jazz Pharmaceuticals

Chief Financial Officer

2020

Robert Ianonne

Jazz Pharmaceuticals

Chief Medical Officer

2020

Robert MSCE

Jazz Pharmaceuticals

Executive Vice President, Global Head of Research and Development

News

You may also like